Virtu Financial LLC Kiromic Biopharma, Inc. Transaction History

Virtu Financial LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 15, 2023	BUY	$0.16 - $11.77 $5,089 - $374,403	31,810 New	31,810 $6,000
Q2 2022 Aug 09, 2022	BUY	$0.26 - $0.87 $6,752 - $22,593	25,970 New	25,970 $11,000
Q4 2021 Feb 17, 2022	SELL	$1.53 - $3.12 $26,703 - $54,453	-17,453 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$2.69 - $4.94 $46,948 - $86,217	17,453 New	17,453 $54,000

107K

Ticker KRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,843,200
Market Cap $15.8M
Description
Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors. The company develops ALEXIS-ISO-1, an allogenic gamma delta CAR-T cell therapy product candidate tar...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.